According to CervoMed's latest financial reports the company's current EPS (TTM) is -$9.54. In 2022 the company made an earnings per share (EPS) of -$11.48 an increase over its 2021 EPS that were of -$18.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$9.54 | -16.86% |
2022 | -$11.48 | -37.65% |
2021 | -$18.40 | -18.2% |
2020 | -$22.50 | -86.06% |
2019 | -$161.41 | -74.74% |
2018 | -$639.00 | -63.37% |
2017 | -$1,744 | -11.89% |
2016 | -$1,980 | -32.05% |
2015 | -$2,914 | -72.12% |
2014 | -$10,453 | -67.01% |
2013 | -$31,683 | -65.84% |
2012 | -$92,747 | -70.56% |
2011 | -$315,070 | 105.74% |
2010 | -$153,142 | 130.87% |
2009 | -$66,331 | 49.72% |
2008 | -$44,304 | 4822.73% |
2007 | -$900.00 |